3rd May 2007 13:18
Skyepharma PLC03 May 2007 For Immediate Release 3 May 2007 SkyePharma PLC ("the Company") The Company was informed that on 1 May 2007 the Trustees of the SkyePharma PLCShare Purchase Plan ("Plan") (a Revenue approved all employee share purchaseplan), purchased an additional 6,406 Ordinary Shares of the Company, at a priceof 22.5 pence per share. Following this transaction, the Trustees hold on behalf of the Plan a total of124,771 Ordinary Shares representing 0.015% of the share capital of the Company. The class of discretionary beneficiaries for whom the Trustees hold such sharesconsists of the employees of the Company, including the following ExecutiveDirectors: Frank Condella and Peter Grant. Each of the Directors is accordinglydeemed to be beneficially interested in the Shares held by the Trustees. In accordance with the rules of the Plan these directors have been awarded theMatching Shares on the basis of one Matching Share for each Partnership Share. The beneficial ownership of the Matching Shares will pass to the directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's directors or any persons discharging managerial responsibility. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L